Federal Register / Vol. 72, No. 95 / Thursday, May 17, 2007 / Notices 27827 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Initial Review Group, Neuroscience of 

Aging Review Committee. 

Date: June 4–5, 2007. 

Time: 3 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Ave., Bethesda, MD 20814. 

Contact Person: Louise L. Hsu, PhD, Health 

Scientist Administrator, Scientific Review 

Office, National Institute on Aging, Gateway 

Building, 7201 Wisconsin Avenue/Suite 

2C212, Bethesda, MD 20892, (301) 496–7705, 

hsul@exmur.nia.nih.gov. 

Name of Committee: National Institute on 

Aging Initial Review Group, Behavior and 

Social Science of Aging Review Committee. 

Date: June 7–8, 2007. 

Time: 4 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Jon E. Rolf, PhD, Scientific 

Review Administrator, Scientific Review 

Office, National Institute on Aging, National 

Institutes of Health, 7201 Wisconsin Avenue/ 

Room 2C212, Bethesda, MD 20814, (301) 

402–7703, rolfj@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Initial Review Group, Clinical Aging 

Review Committee. 

Date: June 7–8, 2007. 

Time: 6 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Alicja L. Markowska, PhD, 

DSC, National Institute on Aging, National 

Institutes of Health, Gateway Building 2C212, 

7201 Wisconsin Avenue, Bethesda, MD 

20892, 301–496–9666, 

markowsa@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Initial Review Group, Biological Aging 

Review Committee. 

Date: June 15, 2007. 

Time: 12 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Bldg., Rm. 2C212, 7201 Wisconsin 

Avenue, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Bita Nakhai, PhD, 

Scientific Review Administrator, Scientific 

Review Office, National Institute on Aging, 

Gateway Bld., 2C212, 7201 Wisconsin 

Avenue, Bethesda, MD 20814, 301–402–

7701, nakhaib@nia.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: May 11, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2448 Filed 5–16–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Recombinant DNA Advisory Committee. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Recombinant DNA 

Advisory Committee. 

Date: June 19–21, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: The Recombinant DNA Advisory 

Committee will review and discuss selected 

human gene transfer protocols as well as 

related data management acivities. There will 

be a discussion of recent results regarding 

immune responses to AAV vectors and a 

discussion of proposed experiments 

involving Chlamydia Trachomatis that would 

require a Major Action under section III–A–

1 of the NIH Guidelines for Research. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Floor 6C, Room 

10, Bethesda, MD 20892. 

Contact Person: Laurie Lewallen, Advisory 

Committee Coordinator, Office of 

Biotechnology Activities, National Institutes 

of Health, 6705 Rockledge Drive, Room 750, 

Bethesda, MD 20892–7985, 301–496–9838, 

lewallla@od.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: 

www4.od.nih.gov/oba/, where an agenda and 

any additional information for the meeting 

will be posted when available. 

OMB’s ‘‘Mandatory Information 

Requirements for Federal Assistance Program 

Announcements’’ (45 FR 39592, June 11, 

1980) requires a statement concerning the 

official government programs contained in 

the Catalog of Federal Domestic Assistance. 

Normally NIH lists in its announcements the 

number and title of affected individual 

programs for the guidance of the public. 

Because the guidance in this notice covers 

virtually every NIH and Federal research 

program in which DNA recombinant 

molecule techniques could be used, it has 

been determined not to be cost effective or 

in the public interest to attempt to list these 

programs. Such a list would likely require 

several additional pages. In addition, NIH 

could not be certain that every Federal 

program would be included as many Federal 

agencies, as well as private organizations, 

both national and international, have elected 

to follow the NIH Guidelines. In lieu of the 

individual program listing NIH invites 

readers to direct questions to the information 

above about whether individual programs 

listed in the Catalog of Federal Domestic 

Assistance are affected. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS). 

Dated: May 11, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2445 Filed 5–16–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of Meeting 

Chairpersons, Board of Scientific 

Counselors for Institutes and Centers at 

the National Institutes of Health 

Notice is hereby given of a meeting 

scheduled by the Deputy Director for 

Intramural Research at the National 

Institutes of Health (NIH) with the 

Chairpersons of the Boards of Scientific 

Counselors. The Boards of Scientific 

Counselors are advisory groups to the 


pwalker on PROD1PC71 with NOTICES